Natixis Investment Managers International’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,703
| Closed | -$376K | – | 623 |
|
|
2018
Q3 | $376K | Buy |
2,703
+897
| +50% | +$125K | 0.02% | 528 |
|
|
2018
Q2 | $224K | Buy |
1,806
+956
| +112% | +$119K | 0.01% | 561 |
|
|
2018
Q1 | $95K | Buy |
850
+808
| +1,924% | +$90.3K | 0.01% | 420 |
|
|
2017
Q4 | $5K | Hold |
42
| – | – | ﹤0.01% | 147 |
|
|
2017
Q3 | $6K | Hold |
42
| – | – | ﹤0.01% | 397 |
|
|
2017
Q2 | $5K | Sell |
42
-7,958
| -99% | -$947K | ﹤0.01% | 401 |
|
|
2017
Q1 | $970K | Sell |
8,000
-49
| -0.6% | -$5.94K | 0.09% | 179 |
|
|
2016
Q4 | $984K | Buy |
+8,049
| New | +$984K | 0.09% | 165 |
|
|
2016
Q2 | – | Sell |
-1,168
| Closed | -$163K | – | 409 |
|
|
2016
Q1 | $163K | Sell |
1,168
-2,086
| -64% | -$291K | 0.02% | 335 |
|
|
2015
Q4 | $621K | Buy |
3,254
+2,086
| +179% | +$398K | 0.08% | 123 |
|
|
2015
Q3 | $183K | Buy |
1,168
+256
| +28% | +$40.1K | 0.02% | 312 |
|
|
2015
Q2 | $165K | Buy |
+912
| New | +$165K | 0.02% | 326 |
|
|
2015
Q1 | – | Sell |
-852
| Closed | -$158K | – | 457 |
|
|
2014
Q4 | $158K | Buy |
+852
| New | +$158K | 0.02% | 290 |
|